There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve chronic disease outcomes for at-risk patients, today announced a ...

Mursla Bio has announced a new collaboration with a leading global pharmaceutical company to support biomarker-guided drug ...

A claque of online anti-vaccine influencers and dissentient researchers are claiming that COVID-19 vaccines are causing an epidemic of aggressive, fast-spreading cancers. The theory, dubbed "turbo ...

AML is a devastating blood cancer with low survival rates, particularly for older patients who cannot tolerate aggressive chemotherapy. Flashpoint's approach offers the potential for a new precision ...

Four new patent applications filed that aim to expand the Curadigm Nanoprimer platform intellectual property portfolio and support an initial ...

From the Napoleonic Wars to the COVID-19 pandemic, discover 32 revolutionary inventions and discoveries that were sparked by ...

According to Nova One Advisor, the global mRNA synthesis & manufacturing market size is calculated at USD 1.58 billion in 2025 and is expected to be hit around USD 1.87 billion by 2034, growing at a ...

Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug ...